论文部分内容阅读
目的:分析氨氯地平联合阿托伐地汀钙片在高血压合并高血脂病患中的临床效果。方法:以我院2010年1月至2013年8月收治的高血压合并高血脂的168例病患为研究对象,随机分为对照组和观察组各84例,在对照组病患中使用常规降压和降脂药物,观察组使用氨氯地平联合阿托伐地汀钙片,而后观察两组病患的临床治疗效果并分析。结果:观察组病患治疗的总体有效率达到92.85%,高于对照组的69.04%,且指标对照中,SBP、DBP、TG、TC、LDL、HDL等改善情况均比对照组更好,两组比较差异具有统计学意义,p<0.05。结论:氨氯地平联合阿托伐地汀钙片在高血压合并高血脂病患的治疗中安全有效,在临床上值得推广。
Objective: To analyze the clinical effect of amlodipine combined with atorvastatin calcium in patients with hypertension and hyperlipidemia. Methods: A total of 168 patients with hypertension complicated with hyperlipidemia admitted to our hospital from January 2010 to August 2013 were randomly divided into control group and observation group, 84 cases in each group. Patients in control group were treated with routine Antihypertensive and lipid-lowering drugs, the observation group using amlodipine combined with atorvastatin calcium tablets, and then observed the clinical efficacy of two groups of patients and analyzed. Results: The overall effective rate of treatment group was 92.85%, which was higher than that of control group (69.04%). In the control group, SBP, DBP, TG, TC, LDL and HDL were all better than the control group Group difference was statistically significant, p <0.05. Conclusion: Amlodipine and atorvastatin calcium tablets are safe and effective in the treatment of hypertension and hyperlipidemia, which is worthy of clinical application.